![A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors | Journal of Nuclear Medicine A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/62/10/1398/F1.large.jpg)
A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors | Journal of Nuclear Medicine
![Blood Journal on X: "A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia https://t.co/lJNxpqQqXK https://t.co/7OcnMKLAjT" / X Blood Journal on X: "A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia https://t.co/lJNxpqQqXK https://t.co/7OcnMKLAjT" / X](https://pbs.twimg.com/media/EclA2eGXYAE9HOs.png:large)
Blood Journal on X: "A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia https://t.co/lJNxpqQqXK https://t.co/7OcnMKLAjT" / X
![The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review](https://hearingreview.com/wp-content/uploads/2017/05/HumesFig1-1000x640.jpg)
The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review
![Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study | npj Aging Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study | npj Aging](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41514-017-0016-9/MediaObjects/41514_2017_16_Fig1_HTML.png)
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study | npj Aging
![Why double-blind randomized trials are so powerful: everything you need to know in 5 minutes - YouTube Why double-blind randomized trials are so powerful: everything you need to know in 5 minutes - YouTube](https://i.ytimg.com/vi/oQt8jR5RgVQ/hqdefault.jpg)
Why double-blind randomized trials are so powerful: everything you need to know in 5 minutes - YouTube
![Design of the randomized, double-blind, controlled, cross-over study in... | Download Scientific Diagram Design of the randomized, double-blind, controlled, cross-over study in... | Download Scientific Diagram](https://www.researchgate.net/publication/237241329/figure/fig1/AS:299478704771073@1448412695171/Design-of-the-randomized-double-blind-controlled-cross-over-study-in-which-subjects.png)
Design of the randomized, double-blind, controlled, cross-over study in... | Download Scientific Diagram
![Study design. A randomized, double-blind, placebo-controlled, crossover... | Download Scientific Diagram Study design. A randomized, double-blind, placebo-controlled, crossover... | Download Scientific Diagram](https://www.researchgate.net/publication/24146123/figure/fig1/AS:310160045166596@1450959325482/Study-design-A-randomized-double-blind-placebo-controlled-crossover-study.png)
Study design. A randomized, double-blind, placebo-controlled, crossover... | Download Scientific Diagram
![Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder - European Urology Focus Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/asset/add3606c-2ce8-4fa1-ba24-9920861ddabc/gr1.jpg)
Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder - European Urology Focus
![A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.](https://dukespace.lib.duke.edu/dspace/bitstream/handle/10161/24821/Cusin_Perlis-2013_Double-blind%2C%20placebo-controlled%20trial%20of%20pramipexole%20augmentation%20in%20treatment-resistant%20major%20depressive%20disorder.pdf.jpg?sequence=4&isAllowed=y)
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.
![Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia - eBioMedicine Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia - eBioMedicine](https://www.thelancet.com/cms/attachment/00973acc-1cd3-459b-9c2a-9912fe11ea4a/gr1.jpg)
Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia - eBioMedicine
![A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0261561419300822-fx1.jpg)
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect
![A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine](https://biblio.ugent.be/publication/8769973/file/01GJFQRZDTV3DNZKM310ZA861F/thumbnail.png)
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
Randomized, double-blind, placebo-controlled clinical trial flow. The... | Download Scientific Diagram
![ELAMIPRETIDE IN PATIENTS WITH BARTH SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL FOLLOWED BY 36-WEEK OPEN-LABEL EXTENSION | Journal of the American College of Cardiology ELAMIPRETIDE IN PATIENTS WITH BARTH SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL FOLLOWED BY 36-WEEK OPEN-LABEL EXTENSION | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/f707f216-ce39-4329-bc3c-2f088569dc01/s0735-1097(20)31584-9.fp.png)